FDA names head of oncology office
Executive Summary
FDA Oncology Division Director Richard Pazdur will head the newly created Office of Oncology Drug Products, effective May 1. The agency announced Pazdur's appointment April 22, nine months after beginning a "national search" for a director (1"The Pink Sheet" July 26, 2004, p. 13). Pazdur has been director of the Oncology Drug Products Division within the Center for Drug Evaluation & Research since September 1999. The new office will consolidate drug, biologic and medical imaging reviews previously handled by three separate offices; the reshuffling is part of broader Office of New Drugs reorganization planned for July...